Market Recap — March 1, 2026
Recap of insider activity, SEC filings, and market-moving news for March 1, 2026.
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Setmelanotide Phase 3 Trial Hits Primary Endpoint with 16.4% BMI Reduction; PDUFA Date Set for March 20
Expanded Phase 3 Data for Setmelanotide Reveals 18.8% BMI Reduction in Hypothalamic Obesity
NIO Sales Soar 58% in February, Outperforming Chinese Peers Amid Sector Slowdown
Dow Futures Plunge 550 Points as Iran War Escalates, Oil Spikes
Pony AI Hits Robotaxi Breakeven in Shenzhen, Paving Way for Scalable Profitability
Berkshire's Q4 Operating Profit Decline Less Severe Than Reported Due to $1.56B Goodwill Write-Down
Septerna's SEP-631 Shows Strong Phase 1 Safety, Advancing to Phase 2 for Mast Cell Diseases
Upstream Bio's Verekitug Hits Primary Endpoint in Phase 2 Nasal Polyp Trial
Barzolvolimab Retreatment Shows Profound Efficacy in Cold Urticaria and SD, Reinforcing Best-in-Class Profile
FedEx Warns of Potential Service Delays Due to Middle East Developments
Activist Elliott Management's Demands Set Stage for Volatile NCLH Earnings
Amazon India Slashes Referral Fees on 125M Products to Drive Merchant Growth
No high-importance items captured for this date.
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Setmelanotide Phase 3 Trial Hits Primary Endpoint with 16.4% BMI Reduction; PDUFA Date Set for March 20
Expanded Phase 3 Data for Setmelanotide Reveals 18.8% BMI Reduction in Hypothalamic Obesity
NIO Sales Soar 58% in February, Outperforming Chinese Peers Amid Sector Slowdown
Dow Futures Plunge 550 Points as Iran War Escalates, Oil Spikes
Pony AI Hits Robotaxi Breakeven in Shenzhen, Paving Way for Scalable Profitability
Berkshire's Q4 Operating Profit Decline Less Severe Than Reported Due to $1.56B Goodwill Write-Down
Septerna's SEP-631 Shows Strong Phase 1 Safety, Advancing to Phase 2 for Mast Cell Diseases
Upstream Bio's Verekitug Hits Primary Endpoint in Phase 2 Nasal Polyp Trial
Barzolvolimab Retreatment Shows Profound Efficacy in Cold Urticaria and SD, Reinforcing Best-in-Class Profile
FedEx Warns of Potential Service Delays Due to Middle East Developments
No notable 8-Ks or news items on this date.
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.